These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1925812)

  • 41. [The effects of inhibition of converting enzyme by perindopril on renal hemodynamics and natriuresis in essential arterial hypertension].
    Chaignon M; Barrou Z; Ayad M; Guédon J
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():151-4. PubMed ID: 3142399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The clinical pharmacology of hypotensive agents. Angiotensin-converting enzyme inhibitors].
    Chekman IS
    Lik Sprava; 1998 Jun; (4):22-6. PubMed ID: 9784696
    [No Abstract]   [Full Text] [Related]  

  • 43. Experience with perindopril in normal volunteers.
    Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular effects of perindopril: from experimental to clinical investigation.
    Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of ACE inhibitors in current clinical practice. The place of perindopril: a review. Proceedings of two symposia. 8 November and 15 November, 1989.
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():1-73. PubMed ID: 1980931
    [No Abstract]   [Full Text] [Related]  

  • 46. Experience with perindopril in normal volunteers.
    Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
    Clin Exp Hypertens A; 1989; 11 Suppl 2():507-19. PubMed ID: 2605800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension.
    Chaignon M; Barrou Z; Ayad M; Lucsko M; Aubert P; Perret L; Guedon J
    J Hypertens Suppl; 1988 Dec; 6(3):S61-4. PubMed ID: 3225690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Psychotropic effects of angiotensin-converting enzyme inhibitors: what are the arguments?].
    Mesure G; Fallet A; Chevalier JF
    Encephale; 1995; 21(5):609-14. PubMed ID: 8529571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
    Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
    Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perindopril for the treatment of hypertension.
    Ghiadoni L
    Expert Opin Pharmacother; 2011 Jul; 12(10):1633-42. PubMed ID: 21599567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement.
    Jackson B; Cubela RB; Johnston CI
    J Pharmacol Exp Ther; 1988 Jun; 245(3):950-5. PubMed ID: 2838609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Principles of choice of an angiotensin-converting enzyme inhibitor: specific features of perindopril].
    Morozova TE; Gontarenko SV; Kuz'mina EP
    Ter Arkh; 2014; 86(9):115-8. PubMed ID: 25518516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of perindopril on renal medullary blood flow: comparison with other antihypertensive treatments.
    Issiakhem M; Liu KL; Benzoni D
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):280-5. PubMed ID: 18356693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disparate effects of antihypertensive drugs on large artery distensibility and compliance in hypertension.
    Van Bortel LM; Kool MJ; Spek JJ
    Am J Cardiol; 1995 Nov; 76(15):46E-49E. PubMed ID: 7484889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional hemodynamic effects of perindopril in congestive heart failure.
    Richard C; Thuillez C; Depret J; Auzépy P; Giudicelli JF
    Am Heart J; 1993 Sep; 126(3 Pt 2):782-8. PubMed ID: 8362753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacokinetics of perindopril in patients with liver cirrhosis.
    Thiollet M; Funck-Brentano C; Grangé JD; Midavaine M; Resplandy G; Jaillon P
    Br J Clin Pharmacol; 1992 Mar; 33(3):326-8. PubMed ID: 1576057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency.
    Verpooten GA; Genissel PM; Thomas JR; De Broe ME
    Br J Clin Pharmacol; 1991 Aug; 32(2):187-92. PubMed ID: 1657092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of perindopril on carbohydrate and lipoprotein metabolism in essential hypertension.
    Giuntoli F; Gabbani S; Natali A; Galeone F; Saba P
    Am J Med; 1992 Apr; 92(4B):95S-97S. PubMed ID: 1580289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.
    Lecocq B; Funck-Brentano C; Lecocq V; Ferry A; Gardin ME; Devissaguet M; Jaillon P
    Clin Pharmacol Ther; 1990 Mar; 47(3):397-402. PubMed ID: 2311339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.